Anavex Life Sciences Corp (AVXL)
5.60
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
5.595
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Shareholders Equity (Annual): 141.85M for Sept. 30, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
September 30, 2023 | 141.85M |
September 30, 2022 | 142.49M |
September 30, 2021 | 150.82M |
September 30, 2020 | 27.24M |
September 30, 2019 | 20.29M |
September 30, 2018 | 22.32M |
September 30, 2017 | 24.25M |
September 30, 2016 | 6.308M |
September 30, 2015 | 12.81M |
September 30, 2014 | 0.1926M |
Date | Value |
---|---|
September 30, 2013 | -2.463M |
September 30, 2012 | -2.875M |
September 30, 2011 | -1.142M |
September 30, 2010 | -2.960M |
September 30, 2009 | -3.858M |
September 30, 2008 | -2.292M |
September 30, 2007 | -0.4625M |
September 30, 2006 | -0.0155M |
September 30, 2005 | -0.026M |
September 30, 2004 | 0.0256M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
27.24M
Minimum
2020
150.82M
Maximum
2021
115.60M
Average
142.17M
Median
Shareholders Equity (Annual) Benchmarks
Baxter International Inc | 8.402B |
Bruker Corp | 1.377B |
BioXcel Therapeutics Inc | -56.51M |
AdaptHealth Corp | 1.458B |
Mirum Pharmaceuticals Inc | 248.67M |